Talicia is now listed as a
FIRST-LINE TREATMENT OPTION
by the American College of
Gastroenterology (ACG)
Empiric use supported by the latest ACG Clinical Guideline—antibiotic susceptibility testing not required
Reference: Chey WD, et al. Am J Gastroenterol. 2024;112(9):1730-1753.
